Cervical cancer prevention and control in women living with human immunodeficiency virus
PE Castle, MH Einstein… - CA: a cancer journal for …, 2021 - Wiley Online Library
Despite being highly preventable, cervical cancer is the fourth most common cancer and
cause of cancer death in women globally. In low‐income countries, cervical cancer is often …
cause of cancer death in women globally. In low‐income countries, cervical cancer is often …
[HTML][HTML] Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective
S Finocchario-Kessler, C Wexler, M Maloba… - BMC women's …, 2016 - Springer
Abstract Background Women living in Africa experience the highest burden of cervical
cancer. Research and investment to improve vaccination, screening, and treatment efforts …
cancer. Research and investment to improve vaccination, screening, and treatment efforts …
[HTML][HTML] Estimates of the global burden of cervical cancer associated with HIV
Background HIV enhances human papillomavirus (HPV)-induced carcinogenesis. However,
the contribution of HIV to cervical cancer burden at a population level has not been …
the contribution of HIV to cervical cancer burden at a population level has not been …
Primary care guidance for persons with human immunodeficiency virus: 2020 update by the HIV Medicine Association of the Infectious Diseases Society of America
MA Thompson, MA Horberg, AL Agwu… - Clinical infectious …, 2021 - academic.oup.com
Advances in antiretroviral therapy (ART) have made it possible for persons with human
immunodeficiency virus (HIV) to live a near expected life span, without progressing to AIDS …
immunodeficiency virus (HIV) to live a near expected life span, without progressing to AIDS …
Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV
This study of SARS-CoV-2 mRNA vaccination in 14 persons with HIV (PWH) demonstrated
uniformly high anti-SARS-CoV-2 receptor binding domain (RBD) antibody titres after two …
uniformly high anti-SARS-CoV-2 receptor binding domain (RBD) antibody titres after two …
Cumulative incidence of cancer among persons with HIV in North America: a cohort study
MJ Silverberg, B Lau, CJ Achenbach, Y Jing… - Annals of internal …, 2015 - acpjournals.org
Background: Cancer is increasingly common among persons with HIV. Objective: To
examine calendar trends in cumulative cancer incidence and hazard rate by HIV status …
examine calendar trends in cumulative cancer incidence and hazard rate by HIV status …
[HTML][HTML] Cervical cancer control in HIV-infected women: past, present and future
Since the initial recognition of acquired immunodeficiency syndrome (AIDS) in 1981, an
increased burden of cervical cancer was identified among human immunodeficiency virus …
increased burden of cervical cancer was identified among human immunodeficiency virus …
A randomized, placebo-controlled trial of the quadrivalent human papillomavirus vaccine in human immunodeficiency virus-infected adults aged 27 years or older …
TJ Wilkin, H Chen, MS Cespedes… - Clinical Infectious …, 2018 - academic.oup.com
Background Adults living with human immunodeficiency virus (HIV) are at increased risk for
anal and oropharyngeal cancer caused by human papillomavirus (HPV). The efficacy of …
anal and oropharyngeal cancer caused by human papillomavirus (HPV). The efficacy of …
[HTML][HTML] Anti-spike antibodies and neutralising antibody activity in people living with HIV vaccinated with COVID-19 mRNA-1273 vaccine: a prospective single-centre …
A Lombardi, GM Butta, L Donnici, G Bozzi… - The Lancet Regional …, 2022 - thelancet.com
Background Vaccines against COVID-19 are a powerful tool to control the current SARS-
CoV-2 pandemic. A thorough description of their immunogenicity among people living with …
CoV-2 pandemic. A thorough description of their immunogenicity among people living with …